113 related articles for article (PubMed ID: 10357252)
1. Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level.
Hertel P; Nomikos GG; Svensson TH
Eur J Pharmacol; 1999 Apr; 371(2-3):153-8. PubMed ID: 10357252
[TBL] [Abstract][Full Text] [Related]
2. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
Wadenberg ML; Wiker C; Svensson TH
Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
Hertel P; Fagerquist MV; Svensson TH
Science; 1999 Oct; 286(5437):105-7. PubMed ID: 10506554
[TBL] [Abstract][Full Text] [Related]
4. Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats.
Matsumoto M; Yoshioka M; Togashi H; Mori K; Ueno K; Saito H
Eur J Pharmacol; 1998 Feb; 343(2-3):165-70. PubMed ID: 9570464
[TBL] [Abstract][Full Text] [Related]
5. Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: role of neuronal activity.
Mathé JM; Nomikos GG; Blakeman KH; Svensson TH
Neuropharmacology; 1999 Jan; 38(1):121-8. PubMed ID: 10193903
[TBL] [Abstract][Full Text] [Related]
6. Regulation of extracellular dopamine by the norepinephrine transporter.
Yamamoto BK; Novotney S
J Neurochem; 1998 Jul; 71(1):274-80. PubMed ID: 9648875
[TBL] [Abstract][Full Text] [Related]
7. The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?
Srinivasan J; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):629-38. PubMed ID: 15118809
[TBL] [Abstract][Full Text] [Related]
8. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
Masana M; Bortolozzi A; Artigas F
Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
[TBL] [Abstract][Full Text] [Related]
9. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex.
Gresch PJ; Sved AF; Zigmond MJ; Finlay JM
J Neurochem; 1995 Jul; 65(1):111-6. PubMed ID: 7790854
[TBL] [Abstract][Full Text] [Related]
10. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
Linnér L; Endersz H; Ohman D; Bengtsson F; Schalling M; Svensson TH
J Pharmacol Exp Ther; 2001 May; 297(2):540-6. PubMed ID: 11303041
[TBL] [Abstract][Full Text] [Related]
11. The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis.
Kawahara H; Kawahara Y; Westerink BH
Eur J Pharmacol; 2001 Apr; 418(3):177-86. PubMed ID: 11343687
[TBL] [Abstract][Full Text] [Related]
12. Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.
Frånberg O; Marcus MM; Ivanov V; Schilström B; Shahid M; Svensson TH
Psychopharmacology (Berl); 2009 Jun; 204(2):251-64. PubMed ID: 19198810
[TBL] [Abstract][Full Text] [Related]
13. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
Devoto P; Flore G; Pani L; Gessa GL
Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
[TBL] [Abstract][Full Text] [Related]
14. Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment.
Youngren KD; Moghaddam B; Bunney BS; Roth RH
Neurosci Lett; 1994 Jan; 165(1-2):41-4. PubMed ID: 8015734
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex.
Liu YP; Wilkinson LS; Robbins TW
Psychopharmacology (Berl); 2004 Apr; 173(1-2):175-85. PubMed ID: 14726995
[TBL] [Abstract][Full Text] [Related]
16. Clonidine reduces dopamine and increases GABA in the nucleus accumbens: an in vivo microdialysis study.
Murai T; Yoshida Y; Koide S; Takada K; Misaki T; Koshikawa N; Cools AR
Pharmacol Biochem Behav; 1998 Jul; 60(3):695-701. PubMed ID: 9678653
[TBL] [Abstract][Full Text] [Related]
17. The α₁-, but not α₂-, adrenoceptor in the nucleus accumbens plays an inhibitory role upon the accumbal noradrenaline and dopamine efflux of freely moving rats.
Saigusa T; Aono Y; Uchida T; Takada K; Verheij MM; Koshikawa N; Cools AR
Eur J Pharmacol; 2012 Aug; 688(1-3):35-41. PubMed ID: 22617026
[TBL] [Abstract][Full Text] [Related]
18. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2004 Sep; 18(3):395-403. PubMed ID: 15358984
[TBL] [Abstract][Full Text] [Related]
19. Loss of dopamine terminals in the medial prefrontal cortex increased the ratio of DOPAC to DA in tissue of the nucleus accumbens shell: role of stress.
King D; Finlay JM
Brain Res; 1997 Sep; 767(2):192-200. PubMed ID: 9367247
[TBL] [Abstract][Full Text] [Related]
20. Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.
Hertel P; Nomikos GG; Schilström B; Arborelius L; Svensson TH
Neuropsychopharmacology; 1997 Jul; 17(1):44-55. PubMed ID: 9194049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
